Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Stem Cell Culture01:17

Stem Cell Culture

6.0K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.0K
Cell Lines01:16

Cell Lines

10.0K
A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
10.0K
Embryonic Stem Cells00:57

Embryonic Stem Cells

4.7K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.7K
Embryonic Stem Cells00:58

Embryonic Stem Cells

32.1K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.1K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sodium crotonate alleviates diabetic cardiomyopathy in association with enhanced histone H3K18 crotonylation.

Scientific reports·2026
Same author

The association between AST/ALT (De Ritis) ratio and osteoporosis or bone mineral density in middle-aged and older adults: A cross-sectional analysis of NHANES data.

Medicine·2026
Same author

Impact of emergency medical services on the prognosis in acute ischemic stroke patients receiving reperfusion therapy or usual treatment: a prospective cohort study.

BMC emergency medicine·2026
Same author

An Inducible hiPSC-Derived Human Podocyte Model for Functional Analysis of TRPC6 Variants Associated with FSGS.

Cells·2026
Same author

Determination of ATP Content in Cells.

Cell proliferation·2026
Same author

Human Pancreatic Cancer Organoids.

Cell proliferation·2026

Related Experiment Video

Updated: Jan 14, 2026

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow
09:03

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Published on: March 17, 2023

2.6K

Development of Stem Cell Data Systems and Associated Data Standards for Cell Therapy.

Yong Zhang1,2,3,4,5, Andreas Kurtz5,6, Hongling Zhao1,4

  • 1Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, China.

Advances in Experimental Medicine and Biology
|October 24, 2025
PubMed
Summary
This summary is machine-generated.

Robust data management is vital for cell-based therapies. Standardized frameworks and emerging technologies like AI can enhance safety, efficacy, and regulatory compliance for stem cell applications.

Keywords:
Cell therapyData interoperabilityStandardsStem cell data systems

More Related Videos

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

11.2K
Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

8.2K

Related Experiment Videos

Last Updated: Jan 14, 2026

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow
09:03

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Published on: March 17, 2023

2.6K
High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

11.2K
Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

8.2K

Area of Science:

  • Biotechnology and Biomedical Engineering
  • Data Science and Management

Background:

  • Cell-based therapies require advanced data management for safety, efficacy, and regulatory adherence.
  • Current data systems face complexities in integrating clinical, manufacturing, and quality control information for stem cell applications.

Purpose of the Study:

  • To review the ISO 8472 series for stem cell data interoperability.
  • To explore the role of emerging technologies in revolutionizing cell therapy data management.
  • To address challenges and outline strategies for implementing data standards in cell therapy manufacturing.

Main Methods:

  • Review of the ISO 8472 series standards.
  • Exploration of artificial intelligence (AI) and blockchain technologies.
  • Analysis of challenges in cell therapy data standardization and transparency.

Main Results:

  • The ISO 8472 series provides a framework for stem cell data interoperability.
  • AI and blockchain offer potential for enhanced data security, automation, and management.
  • Collaboration among stakeholders is crucial for overcoming implementation challenges.

Conclusions:

  • Comprehensive data standards and interoperable systems are essential for the commercialization of cell therapies.
  • Standardized data management builds trust and facilitates innovation in the field.
  • Proactive strategies are needed to ensure transparency and scalability in cell therapy manufacturing.